These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29079763)

  • 21. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.
    Takeuchi M; Takino JI; Sakasai-Sakai A; Takata T; Tsutsumi M
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28632197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
    Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
    Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells.
    Senavirathna L; Ma C; Chen R; Pan S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33923186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glyceraldehyde-derived advanced glycation end products (AGEs). A novel biomarker of postprandial hyperglycaemia in diabetic rats.
    Kitahara Y; Takeuchi M; Miura K; Mine T; Matsui T; Yamagishi S
    Clin Exp Med; 2008 Sep; 8(3):175-7. PubMed ID: 18791692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
    Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
    Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
    Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
    Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
    J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T; Zhu J; Zhu L; Cheng M
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
    Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
    Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chebulic acid prevents hepatic fibrosis induced by advanced glycation end-products in LX-2 cell by modulating Nrf2 translocation via ERK pathway.
    Koo YC; Pyo MC; Nam MH; Hong CO; Yang SY; Lee KW
    Toxicol In Vitro; 2016 Aug; 34():8-15. PubMed ID: 27021876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
    Al-Hussaini H; Kilarkaje N
    Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products.
    Ishibashi Y; Matsui T; Nakamura N; Sotokawauchi A; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2017 Sep; 14(5):450-453. PubMed ID: 28631505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
    Ganji SH; Kashyap ML; Kamanna VS
    Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells.
    Takino JI; Sato T; Kanetaka T; Okihara K; Nagamine K; Takeuchi M; Hori T
    Sci Rep; 2021 Feb; 11(1):2959. PubMed ID: 33536515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.